Medicinal Products Reimbursement

Dáil Éireann Debate, Thursday - 30 November 2017

Thursday, 30 November 2017

Ceisteanna (167)

John Curran

Ceist:

167. Deputy John Curran asked the Minister for Health if the HSE recently met the company that manufactures the drug Respreeza; if arrangements have now been put in place with the company and the HSE to administer Respreeza to the 21 persons who had been receiving it as part of a clinical trial; and if he will make a statement on the matter. [51369/17]

Freagraí scríofa

Minister for Health

The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.